Chapter 10. New therapies for parasitic infection
- 1 January 2001
- book chapter
- Published by Elsevier
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- Reaching Maturity — 25 Years of the TDRParasitology Today, 2000
- Antimalarial Drug Development and New TargetsParasitology Today, 2000
- Antimalarial, Antiproliferative, and Antitumor Activities of Artemisinin-Derived, Chemically Robust, Trioxane DimersJournal of Medicinal Chemistry, 1999
- Malaria A blueprint of ‘bad air’Nature, 1999
- The complete nucleotide sequence of chromosome 3 of Plasmodium falciparumNature, 1999
- New 4-Aminoquinoline Mannich Base Antimalarials. 1. Effect of an Alkyl Substituent in the 5‘-Position of the 4‘-Hydroxyanilino Side ChainJournal of Medicinal Chemistry, 1999
- Orally Active, Hydrolytically Stable, Semisynthetic, Antimalarial Trioxanes in the Artemisinin FamilyJournal of Medicinal Chemistry, 1998
- Prophylaxis of Plasmodium falciparum Infection in a Human Challenge Model with WR 238605, a New 8-Aminoquinoline AntimalarialAntimicrobial Agents and Chemotherapy, 1998
- Structure−Activity Relationships of the Antimalarial Agent Artemisinin. 5. Analogs of 10-Deoxoartemisinin Substituted at C-3 and C-9Journal of Medicinal Chemistry, 1996
- Evidence for the Importance of High-Valent FeO and of a Diketone in the Molecular Mechanism of Action of Antimalarial Trioxane Analogs of ArtemisininJournal of the American Chemical Society, 1996